Prognostic influence of blood transfusion on minimal residual disease in resected gastric cancer patients
M.M. Heiss, H. Allgayer, and K.U. Gruetzner Prognostic influence of blood transfusion on minimal residual disease in resected gastric cancer patients Anticancer Res 17 1997 2657 2661
Factors influencing the development of wound infection following free-flap reconstruction for intra-oral cancer
D.J. Cloke, J.E. Green, A.L. Khan, P.D. Hodgkinson, and N.R. McLean Factors influencing the development of wound infection following free-flap reconstruction for intra-oral cancer Br J Plast Surg 57 2004 556 560
The influence of perioperative transfusions on the immunological profile of patients with colorectal adenocarcinoma
Y. Ziv, B. Shohat, I. Gelerenter, and Y. Wolloch The influence of perioperative transfusions on the immunological profile of patients with colorectal adenocarcinoma Panminerva Med 34 1992 4 12
A cost analysis of autologous and allogeneic transfusions in hip replacement surgery
N. Blumberg, S.A. Kirkley, and J.M. Heal A cost analysis of autologous and allogeneic transfusions in hip replacement surgery Am J Surg 171 1996 324 330
In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer
H. Nagai, T. Horikawa, and I. Hara In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer Exp Dermatol 13 2004 613 620
Soluble HLA class I, HLA Class II, and fas ligand in blood components: A possible key to explain the immunomodulatory effects of allogeneic blood transfusions
M. Ghio, P. Contini, and C. Mazzei Soluble HLA class I, HLA Class II, and fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions Blood 93 1999 1770 1777